Literature DB >> 29393054

Primary Thyroid Lymphoma: External Beam Radiation Therapy Induced Thyroiditis Mimics Residual Disease on Serial 18F-FDG PET/CT Imaging.

William Makis1, Anthony Ciarallo2, Stephan Probst3.   

Abstract

A 67-year-old female patient with no prior history of benign thyroid disease was diagnosed with primary thyroid lymphoma and was staged with 18F-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). She was treated with chemotherapy and external beam radiation therapy, and a follow-up PET/CT showed significant reduction in the size of the thyroid lymphoma with persistent intense 18F-FDG uptake, which was interpreted as partial response to therapy. However, two subsequent PET/CT studies showed no change in the persistent intense 18F-FDG uptake in the thyroid and a biopsy confirmed the presence of thyroiditis with no evidence of residual lymphoma. Follow-up PET/CTs performed over the subsequent three years showed stable intensely 18F-FDG avid thyroiditis with no evidence of lymphoma recurrence. We present the imaging characteristics of a long term radiation treatment induced thyroiditis mimicking 18F-FDG avid residual disease on PET/CT.

Entities:  

Keywords:  18F-FDG PET.; Thyroid lymphoma; artifact; pitfall; thyroiditis

Year:  2018        PMID: 29393054      PMCID: PMC5790974          DOI: 10.4274/mirt.07088

Source DB:  PubMed          Journal:  Mol Imaging Radionucl Ther


  10 in total

1.  Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers.

Authors:  Regiane S Andrade; Dwight E Heron; Berna Degirmenci; Pedro A A Filho; Barton F Branstetter; Raja R Seethala; Robert L Ferris; Norbert Avril
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-05       Impact factor: 7.038

2.  FDG PET/CT for assessing therapy response in primary thyroid lymphoma.

Authors:  Eugene C Lin
Journal:  Clin Nucl Med       Date:  2007-02       Impact factor: 7.794

Review 3.  Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment.

Authors:  Amanda Graff-Baker; Julie Ann Sosa; Sanziana A Roman
Journal:  Curr Opin Oncol       Date:  2010-01       Impact factor: 3.645

4.  The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.

Authors:  Min Yao; Russell B Smith; Michael M Graham; Henry T Hoffman; Huaming Tan; Gerry F Funk; Scott M Graham; Kristi Chang; Kenneth J Dornfeld; Yusuf Menda; John M Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-15       Impact factor: 7.038

5.  Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study.

Authors:  C Onal; Y X Li; R C Miller; P Poortmans; N Constantinou; D C Weber; B M Atasoy; S Igdem; M Ozsahin; E Ozyar
Journal:  Ann Oncol       Date:  2010-06-29       Impact factor: 32.976

Review 6.  An evidence-based approach to the treatment of thyroid lymphoma.

Authors:  Lloyd A Mack; Janice L Pasieka
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

7.  Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.

Authors:  Amanda Graff-Baker; Sanziana A Roman; Daniel C Thomas; Robert Udelsman; Julie Ann Sosa
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

8.  Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.

Authors:  S Basu; G Li; G Bural; A Alavi
Journal:  Acta Radiol       Date:  2009-03       Impact factor: 1.990

9.  Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.

Authors:  R Kubota; S Yamada; K Kubota; K Ishiwata; N Tamahashi; T Ido
Journal:  J Nucl Med       Date:  1992-11       Impact factor: 10.057

10.  Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.

Authors:  Seiji Kurata; Masatoshi Ishibashi; Yuji Hiromatsu; Hayato Kaida; Ikuyo Miyake; Masafumi Uchida; Naofumi Hayabuchi
Journal:  Ann Nucl Med       Date:  2007-08-27       Impact factor: 2.668

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.